<?xml version='1.0' encoding='utf-8'?>
<document id="27891633"><sentence text="Direct inhibition of Re Du Ning Injection and its active compounds on human liver cytochrome P450 enzymes by a cocktail method." /><sentence text="The aim of this study was to investigate the direct inhibitory effects of Re Du Ning Injection (RDN) and its active compounds on the major cytochrome P450 enzyme (CYP) isoforms (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 and CYP3A4) of human liver microsomes by 'a cocktail method'" /><sentence text=" The activity of each CYP isform was represented as the formation rate of the specific metabolite from relevant substrate" /><sentence text=" Then a sensitive and specific ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed and validated to simultaneously analyze the seven metabolites" /><sentence text=" RDN (0" /><sentence text="035-2" /><sentence text="26 mg/mL) showed a strong inhibitiory effect on CYP2C8, followed by CYP2C9, CYP2B6, CYP2C19, CYP1A2 and CYP3A4" /><sentence text=" The IC50 value for each enzyme was 0" /><sentence text="19, 0" /><sentence text="66, 0" /><sentence text="72, 1" /><sentence text="27, 1" /><sentence text="66 and 2" /><sentence text="13 mg/mL, respectively" /><sentence text=" RDN competitively inhibited the activities of CYP1A2 (Ki  = 1" /><sentence text="22 mg/mL), CYP2B6 (Ki  = 0" /><sentence text="65 mg/mL) and CYP3A4 (Ki  = 0" /><sentence text="88 mg/mL); it also exhibited mixed inhibition of CYP2C8, CYP2C9 and CYP2C19 with a Ki value of 0" /><sentence text="26, 0" /><sentence text="64 and 0" /><sentence text="82 mg/mL, respectively" /><sentence text=" However, the activity of CYP2D6 was not significantly inhibited even by 2" /><sentence text="26 mg/mL RDN" /><sentence text=" Moreover, the data of nine active compounds on the CYPs showed that cryptochlorogenin acid, sochlorogenic acid B and sochlorogenic acid C were the major contributors to the inhibitory effect of RDN on CYP2C8, while the inhibitory effect of RDN on CYP2C9 might be caused by sochlorogenic acid A and sochlorogenic acid C"><entity charOffset="69-91" id="DDI-PubMed.27891633.s24.e0" text="cryptochlorogenin acid" /><entity charOffset="93-113" id="DDI-PubMed.27891633.s24.e1" text="sochlorogenic acid B" /><entity charOffset="118-138" id="DDI-PubMed.27891633.s24.e2" text="sochlorogenic acid C" /><entity charOffset="274-294" id="DDI-PubMed.27891633.s24.e3" text="sochlorogenic acid A" /><entity charOffset="299-319" id="DDI-PubMed.27891633.s24.e4" text="sochlorogenic acid C" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e0" e2="DDI-PubMed.27891633.s24.e0" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e0" e2="DDI-PubMed.27891633.s24.e1" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e0" e2="DDI-PubMed.27891633.s24.e2" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e0" e2="DDI-PubMed.27891633.s24.e3" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e0" e2="DDI-PubMed.27891633.s24.e4" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e1" e2="DDI-PubMed.27891633.s24.e1" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e1" e2="DDI-PubMed.27891633.s24.e2" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e1" e2="DDI-PubMed.27891633.s24.e3" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e1" e2="DDI-PubMed.27891633.s24.e4" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e2" e2="DDI-PubMed.27891633.s24.e2" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e2" e2="DDI-PubMed.27891633.s24.e3" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e2" e2="DDI-PubMed.27891633.s24.e4" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e3" e2="DDI-PubMed.27891633.s24.e3" /><pair ddi="false" e1="DDI-PubMed.27891633.s24.e3" e2="DDI-PubMed.27891633.s24.e4" /></sentence><sentence text=" Moreover, neochlorogenic acid might be the major contributor to the inhibitory effect on CYP2B6"><entity charOffset="11-30" id="DDI-PubMed.27891633.s25.e0" text="neochlorogenic acid" /></sentence><sentence text=" All of the findings suggested that drug-drug interactions may occur and great caution should be taken when RDN is combined with drugs metabolized by these CYPs" /><sentence text="" /></document>